ZNF195 is one of the most significant survival-associated genes in bladder cancer [35] and has been previously reported as a biomarker for gemcitabine sensitivity in head and neck squamous cell carcinoma [36]. This evidence concerns the gene ZNF195 and head and neck squamous cell carcinoma.